A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 243
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NPSLE
Long Form : neuropsychiatric systemic lupus erythematosus
No. Year Title Co-occurring Abbreviation
2020 A Novel Microglia-Specific Transcriptional Signature Correlates With Behavioral Deficits in Neuropsychiatric Lupus. DAM
2020 Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus. CSF, NMDARs, SLE
2020 Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus. SLE
2020 Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice. GC-MS, PCA, SLE
2020 Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus. auto Abs, BBB, CSF, DN, DP, IMs, MIG, NR2
2020 Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus. BEL, LN, SLE
2020 Comprehensive expression profile of long non-coding RNAs in Peripheral blood mononuclear cells from patients with neuropsychiatric systemic lupus erythematosus. DE, GO, lncRNAs, mRNAs, PBMCs
2020 Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India. aCL, beta2GP1, CI, LA, OR, SLE
2020 Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus? SLE, SLEDAI, TWEAK
10  2020 Neuroprotective effect of microglia against impairments of auditory steady-state response induced by anti-P IgG from SLE patients in naive mice. ASSR, BBB, EEG
11  2020 Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey. ACR, AUC, CI, PPV
12  2020 Prevalence of neuropsychiatric lupus in psychosis patients with a positive antinuclear antibody. ANA
13  2020 Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus. CD, ELISA, MoCA, SLE
14  2020 Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study. CRP, CSF
15  2020 Quantitative Identification of Functional Connectivity Disturbances in Neuropsychiatric Lupus Based on Resting-State fMRI: A Robust Machine Learning Approach. ---
16  2020 The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines. BBB, CSF
17  2020 What are the latest clinical findings regarding the association of neurotoxic brain antibodies found in the cerebrospinal fluid in patients with autoimmune disorders? BBB
18  2019 A challenging case of neuropsychiatric systematic lupus erythematosus with recurrent antiphospholipid- related stroke: A case report and literature review. aPL
19  2019 Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus. aCL, CRP, ELISA, ESR, Hb, PLT, SLE, SLICC/ACR, WBC
20  2019 Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus. BBB, SLE
21  2019 Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus. aCL, anti-dsDNA
22  2019 Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus. AUC, CNS, CSF, SLE
23  2019 Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus. HC, NR2
24  2019 Clinical, neuroimaging and immunological phenotype of South African neuropsychiatric systemic lupus erythematosus patients. MRI, WMH
25  2019 Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice. i.p
26  2019 Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus. ---
27  2019 Interferon-alpha exacerbates neuropsychiatric phenotypes in lupus-prone mice. ELISA, PAS, RT-qPCR
28  2019 Neuroinflammation in systemic lupus erythematosus - a review. BBB, CNS, NPS, SLE
29  2019 The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus. CSF, CTD, mNPSLE, NSD, sNPSLE, UCH-L1
30  2019 Update on the pathogenesis of central nervous system lupus. BBB, CNS
31  2019 Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus. CSF, LN
32  2019 [Neuropathology of Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)]. ---
33  2018 A Brain Ring-Enhancing Lesion. ---
34  2018 A Conscious Resting State fMRI Study in SLE Patients Without Major Neuropsychiatric Manifestations. HC, ReHo, rs-fMRI, SLE
35  2018 Blood-brain barrier dysfunction in immuno-mediated neurological diseases. AQP4, BBB, MS, NMO, SP
36  2018 Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus. CNS, CRP, CSF, SLE, SLEDAI
37  2018 Identification of Levels of Serum Amyloid A and Apolipoprotein A1 in Serum Proteomic Analysis of Neuropsychiatric Systemic Lupus Erythematosus Patients. ApoA1, HDL, MS, SAA
38  2018 Jaw Dystonia and Reversible Basal Ganglia Changes as an Initial Presentation of Systemic Lupus Erythematosus. ---
39  2018 Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus. CSF, MS, NPH, SBSN, SLE
40  2018 Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study. ACR, SLEDAI, SLICC
41  2018 Proteomic approach to profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous system autoimmune diseases. CSF, ICs
42  2018 Psycho-rheumatic Integration in Systemic Lupus Erythematosus: An Insight into Antibodies Causing Neuropsychiatric Changes. NMDAR
43  2018 Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus. ACS, BBB
44  2018 Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets? AQP4, dsDNA, MOG, NMOSD
45  2017 A case of neuropsychiatric lupus Erythematosus characterized by the Owl's eye sign: a case report. SLE
46  2017 Advanced MRI techniques: biomarkers in neuropsychiatric lupus. DTI, GM, SLE, WM
47  2017 Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study. FM, NMDARs, SLE
48  2017 Association of anti-triosephosphate isomerase antibodies with aseptic meningitis in patients with neuropsychiatric systemic lupus erythematosus. ELISA, TPI
49  2017 Autoantibodies against myelin sheath and S100beta are associated with cognitive dysfunction in patients with rheumatoid arthritis. CNS, DVR, RA, S100beta
50  2017 Brain MRI in patients with acute confusional state of diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. ACS
51  2017 Central Nervous System Manifestations of Systemic Lupus Erythematosus. ---
52  2017 Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus. BBB, CSF, LN
53  2017 Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosus. CSF, DNPSLE, FNPSLE, sFKN, SLEDAI
54  2017 Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus. ACS, BBB, ELISA, IL, Q C3, Qalpha2MG
55  2017 Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases. miRNAs, MS, NMOSD, qRT-PCR, SMAD3, Sp1, SPMS
56  2017 Neurological Manifestations in Systemic Lupus Erythematosus: A Single Centre Study from North East India. ARA, SLE, SLEDAI
57  2017 Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients? ---
58  2017 Primary Psychiatric Disorder Masking the Diagnosis of Neuropsychiatric Lupus in a Patient with Altered Mental Status: A Case Report. AMS, ANA, CSF, MRI, SLE, SLICC
59  2017 [The clinical significance of anti- ubiquitin C-terminal hydrolase L1 autoantibodies in the diagnosis of neuropsychiatric systemic lupus erythematosus]. ELISA, UCHL-1
60  2016 A Comprehensive Rehabilitation Approach in a Patient With Serious Neuropsychiatric Systemic Lupus Erythematosus. SLE
61  2016 A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. Abs, aCL, aPL, CSF, LA, OR
62  2016 Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus. CSF, MAP-2
63  2016 Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. aa, ELISA, mNR1, NMDA, NR1
64  2016 Changes in White Matter Microstructure Suggest an Inflammatory Origin of Neuropsychiatric Systemic Lupus Erythematosus. CNS, GM, MTR-HPHs, WM
65  2016 Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study. CYC
66  2016 Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus. ---
67  2016 Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites. ---
68  2016 IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus. CNS, CSF
69  2016 Is it primary neuropsychiatric systemic lupus erythematosus? Performance of existing attribution models using physician judgment as the gold standard. SLICC
70  2016 Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: A prospective study of 100 psychiatric inpatients. ANA, DNA, ENA, SLE, SSA
71  2016 Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. NP, SLE
72  2016 Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran. CVD, SLE
73  2016 Predictors of clinical outcomes in patients with neuropsychiatric systemic lupus erythematosus. CI, CSF, IFN-gamma, IL, OR, TNF-alpha, WV
74  2016 Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia. QSM
75  2016 Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus. CA, CI, MRI, OR, RD, SLEDAI
76  2016 Soluble alpha-klotho is a potential biomarker associated with neuropsychiatric systemic lupus erythematosus. CSF, MS, NMO, SLE, VM
77  2016 The Neurochemical and Microstructural Changes in the Brain of Systemic Lupus Erythematosus Patients: A Multimodal MRI Study. DKI, HCs, PCG, VBM
78  2016 Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus. CSF, NP, TNF
79  2015 A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus. AD, DTI, FA, FLAIR, HC, MD, MTI, MTR, NAWM, NP, RD, SLE
80  2015 Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus. CNS, SLE
81  2015 Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. anti-P, LPS, NSPA
82  2015 Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus. CSF
83  2015 Automatic Segmentation of the Corpus Callosum Using a Cell-Competition Algorithm: Diffusion Tensor Imaging-Based Evaluation of Callosal Atrophy and Tissue Alterations in Patients With Systemic Lupus Erythematosus. CNS, DTI, FA, MD
84  2015 Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE). IDO, IFN-gamma, IL-10, VCAM-1
85  2015 Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions. ACR, DWI, MRI
86  2015 Detection of cerebral microvascular lesions using 7 T MRI in patients with neuropsychiatric systemic lupus erythematosus. T1WIs
87  2015 Discriminating infectious meningitis versus neuropsychiatric involvement in patients with systemic lupus erythematosus: a single-center experience. CSF, SLEDAI
88  2015 Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases. CSF, FGF, IFN, IL, MS, NMO
89  2015 Integrative neuroscience approach to neuropsychiatric lupus. ---
90  2015 Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-beta2GPI antibodies in patients with systemic lupus erythematosus. aCL, anti-beta2GPI, aPL, CVD, LA
91  2015 Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus. SLE
92  2015 Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus. CNS, CT, LN, MRI, PET, SLE, US
93  2015 Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model. AMPAR, EPSP, LTP, NMDAR, NSPA
94  2015 Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE. RNFL, SD-OCT
95  2015 Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus? ACR, NP, NSE, SLAM, SLE
96  2015 Successful Treatment of Lupus Cerebrovascular Disease with Mycophenolate Mofetil. AZ, IL-6, MMF
97  2015 TRPC6 gene variants and neuropsychiatric lupus. NMDA, SLE, TRPC6
98  2015 [Systemic lupus erythematosus of the nervous system--selected aspects]. CNS
99  2014 Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus. Abs, CSF, IMs
100  2014 Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus. ACS, BBB, CSF, ELISA